The Phase 2b trial is a double-blind, multi-center, randomized, comparator-controlled study to determine the relative efficacy, safety, and immunogenicity of Vaxart’s oral pill COVID-19 vaccine ...

Vaccination of 27- to 45-year-olds against HPV is less cost-effective than vaccination of younger persons (aged 9 to 26 years).

A new study provides good evidence that the human papillomavirus (HPV) vaccine may be achieving its goal of slashing rates of ...

The statistics are alarming. Every two minutes, a woman dies of cervical cancer in countries where access to public health, ...

Cervical cancer deaths have plunged dramatically among women under age 25, and researchers at MUSC Hollings Cancer Center ...

Robert F. Kennedy Jr., President-elect Donald Trump’s pick to oversee the nation’s health system, worries the medical ...

Delve into the expanding and diverse field of cancer vaccines with various approaches exploiting the immune system to fight ...

Human papillomavirus (HPV) is a common viral infection typically transmitted through intimate contact, primarily during ...

Cervical cancer, considered a “highly preventable” disease, has long been declining in the United States — but it’s now on ...

In the vibrant streets of Nairobi, a silent health crisis is unfolding, casting a shadow over the lives of gay, bisexual, and ...

Gen Z is largely ready for an inter-generational truce to take place. And now for the hard-hitting question: Are you?

For too long, men's health has been sidelined in the HIV response, leading to missed opportunities for early intervention and ...